News | July 06, 2012

Study reports 79 percent of diagnosis/treatment differed after review of brain SPECT images


July 6, 2012 — A new study titled “Specific Ways Brain SPECT Imaging Enhances Clinical Psychiatric Practice” was published June in the Journal of Psychoactive Drugs. It reveals how brain SPECT (single photon emission computed tomography) imaging can help clinicians more accurately diagnose and treat a wide variety of mental conditions by looking at the organ responsible for the decision-making, behaviors and overall cognitive functioning.

Co-authored by Daniel G. Amen, M.D., founder of Amen Clinics Inc; Kristen Willeumier, Ph.D. and Joseph Annibali, M.D., the study asked seven board-certified psychiatrists to evaluate 109 patients' files without the SPECT images and give their professional diagnosis and recommended treatment. After they saw the SPECT scans, 79 percent of the diagnosis and/or treatment would have been different. Additionally 22 percent of the patients showed unexpected brain injury and/or toxicity, while 60 percent showed new targets for medication or supplements.

"The SPECT images help the clinician understand where the brain is not functioning properly, so they can give a more accurate diagnosis and treatment offering," said Amen. He has conducted more than 73,000 SPECT scans on patients from 90 countries in the last 20 years.

"In our study, the use of SPECT neuroimaging modified the diagnostic thinking and led clinicians to make different, specific treatment recommendations in a high percentage of cases," wrote Amen, a board-certified child and adult psychiatrist.

Brain SPECT imaging is a form of neuroimaging that reveals the underlying physiology of emotional, behavioral and cognitive disorders such as anxiety, depression, ADD, memory loss, Alzheimer's, addiction, autism, seizures, strokes, toxic exposure and post-traumatic stress disorder.

For more information: www.amenclinics.com


Related Content

News | Radiopharmaceuticals and Tracers

September 22, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time September 22, 2022
arrow
News | Women's Health

September 20, 2022 — Scientists from The Tisch Cancer Institute have uncovered a mechanism by which certain breast ...

Time September 20, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

September 15, 2022 — University of Minnesota Twin Cities scientists and engineers have found a way to improve the ...

Time September 15, 2022
arrow
News | Radiation Therapy

September 15, 2022 — The intestine is very susceptible and is affected by the harsh conditions caused by DNA-altering ...

Time September 15, 2022
arrow
Feature | Contrast Media | By Christine Book

The theme “Everyday progress” seems appropriate for the imaging community in 2022. What a year it’s been. Supply ...

Time September 14, 2022
arrow
News | SPECT-CT

September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...

Time September 12, 2022
arrow
News | SPECT-CT

September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...

Time September 07, 2022
arrow
News | Proton Therapy

September 2, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, today ...

Time September 02, 2022
arrow
News | Radiopharmaceuticals and Tracers

August 26, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time August 25, 2022
arrow
News | Proton Therapy

August 19, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

Time August 19, 2022
arrow
Subscribe Now